ImmunoGenesis Appoints Oncology Research Veteran to Lead Immuno-Oncology Clinical Development Targeting Immune-Excluded, Cold Cancers

/PRNewswire/ -- ImmunoGenesis, a clinical-stage biotechnology company developing science-driven immune therapies, announced the appointment of seasoned...

Related Keywords

University Of Pennsylvania ,Pennsylvania ,United States ,Houston ,Texas ,Philadelphia College Of Pharmacy ,Philadelphia ,Charles Schweizer ,James Barlow ,Jennifer Guinan ,Prnewswire Immunogenesis ,Product Development ,University Of The Sciences ,Immunogenesis Inc ,Clinical Development ,Senior Vice President ,Therapeutic Area Head ,Immunogenesis President ,Vice President ,Clinical Operations ,Galera Therapeutics ,Pharmaceutical Product ,Health Policy ,Philadelphia College ,Private Securities Litigation Reform Act ,Immunogenesis ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Pharmaceuticals ,Personnel Announcements ,